Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04074577 · ClinicalTrials.gov registry record · NA
Computer Aided Detection, Tandem Colonoscopy Study
A NA study of Colonic Diseases, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT04074577: Completed NA study of Colonic Diseases, sponsored by NYU Langone Health.
NCT04074577 is a NA study of Colonic Diseases that has completed, run by NYU Langone Health. The registered enrollment target is 32 participants, below the 286-participant average among 6 other Colonic Diseases trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04074577, a NA study of Colonic Diseases, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to examine the role of machine learning and computer aided diagnostics in automatic polyp detection and to determine in real-time how a computer-aided detection (CADe) algorithm will perform when compared to standard screening or surveillance colonoscopy alone. Design will be a multi-center, prospective, unblinded randomized tandem colonoscopy study. 196 patients referred for either screening or surveillance colonoscopy will be included.
Primary Outcome
AMR will be calculated as the number of adenomas detected on the second pass or portion in either group divided by the total number of adenomas detected during both passes.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Standard technique First
- DIAGNOSTIC_TEST combination technique First
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2020-09-17 |
| Est. Completion | 2020-10-14 |
| Phase | NA |
What the finished NCT04074577 record still lists
NCT04074577 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 286-participant average among 6 other Colonic Diseases trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Colonic Diseases appearing as the primary indexed condition, and to 2 interventions - of which Standard technique First is the first listed.
NCT04074577 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04074577 about?
NCT04074577 is a clinical study titled "Computer Aided Detection, Tandem Colonoscopy Study". The purpose of this project is to examine the role of machine learning and computer aided diagnostics in automatic polyp detection and to determine in real-time how a computer-aided detection (CADe) algorithm will perform when compared to standard screening or surveillance colonoscopy alone. Design ...
What is the current status of trial NCT04074577?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2020-09-17. Estimated completion is 2020-10-14.
What conditions does trial NCT04074577 study?
This clinical trial studies the following conditions: Colonic Diseases.
What interventions are being tested in trial NCT04074577?
The interventions under investigation include: Standard technique First (DIAGNOSTIC_TEST), combination technique First (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04074577?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04074577 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonic Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
RECRUITING · NA
-
The Impact of Diet Liberalization on Bowel Preparation for Colonoscopy
COMPLETED · NA
-
Evaluation of PillCam™ Colon 2 in Visualization of the Colon
COMPLETED · NA
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RECRUITING · Phase 3
-
A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy
COMPLETED · Phase 2
-
A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI